Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02

Url canonique :
Url courte ou permalien :

Darwin's Medicine How Business Models in the Life Sciences Industry are Evolving

Langue : Anglais

Auteur :

Darwin’s Medicine is the sequel to Brian D. Smith’s influential and critically acclaimed Future of Pharma (Gower, 2011). Whereas the earlier book predicted the evolution of the pharmaceutical market and the business models of pharmaceutical companies, Darwin’s Medicine goes much deeper into the drivers of industry change and how leading pharmaceutical and medical technology companies are adapting their strategies, structures and capabilities in practice.

Through the lens of evolutionary science, Professor Smith explores the speciation of new business models in the Life Sciences Industry. This sophisticated and highly original approach offers insights into:

  • The mechanisms of evolution in this exceptional industry;
  • The six great technological and social shifts that are shaping its landscape;
  • The emergence of 26 distinct, new business models; and
  • The lessons that enable firms to direct and accelerate their own evolution.

These insights map out the industry’s complex, changing landscape and provide an invaluable guide to those firms seeking to survive and thrive in this dynamic market.

The book is essential reading for anyone working in or studying the pharmaceutical, medical technology and related sectors. It provides a unique and novel way of making sense of the transformation we can see going on around us and a practical, focused approach to managing a firm’s evolutionary trajectory. 

Part 1: The Future of Pharma - Reprise
. 1. Introduction and an Invitation to Skip a Chapter
. 2. An Important Industry at Risk
. 3. The Best Idea Anyone Has Ever Had
. 4. The Biologists Got There First
. 5. Applying Evolutionary Theory to the Pharmaceutical and Medical Technology Sectors
. 6. Explaining the Industry’s Past
. 7. Predicting the Future of Pharma and Medtech
. 8. Practical Implications for an Evolving Industry
. 9. Watching the Future Unfold

Part 2: An Immeasurably Superior Power
. 10. Introduction: The Emergent Pressures of Selection
. 12. Selection Pressures Emerging from the Technological Environment
. 13. Asking the Right Questions

Part 3: Evolution is Cleverer Than You Are
. 14. Introduction: Orgel’s Second Law
. 15. Technological Innovator Species Emerging in the Government Payer Habitat
. 16. Technological Innovator Species Emerging in Patient Payer Habitats
. 17. Operationally Excellent Species Emerging in the Government Payer Habitat
. 18. Operationally Excellent Species Emerging in Patient Payer Habitats
. 19. Customer Intimate Species Emerging in the Government Payer Habitat
. 20. Customer Intimate Species Emerging in Patient Payer Habitats
. 21. A Big Bang of Life Science Business Models

Part 4: Guiding the Blind Watchmaker
. 22. Introduction: From Description to Prescription
. 23. Which Fitness Peak(s) Should We Climb?
. 24. What Capabilities Does Our New Business Model Need?
. 25. How Should We Design a Capable Holobiont?
. 26. How Do We Build Our Core Capabilities?

Date de parution :

Ouvrage de 282 p.

17.4x24.6 cm

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

Prix indicatif 142,26 €

Ajouter au panier
En continuant à naviguer, vous autorisez Lavoisier à déposer des cookies à des fins de mesure d'audience. Pour en savoir plus et paramétrer les cookies, rendez-vous sur la page Confidentialité & Sécurité.